logo
Select company
Select metric
$ -21.69MWorking Capital
VS
Market
13
Sector
4
Industry
2
History
-
$ 0.61Close
$ 0.36 - $ 4.96 52-Week Range
Ticker Information

Ticker

IBO

Company Name

IMPACT BIOMEDICAL INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

IMPACT BIOMEDICAL INC - Working Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IBO - Working Capital Historical data
DateCurrent AssetsCurrent LiabilitiesWorking Capital
6/30/2025$ 1.48M$ 23.17M$ -21.69M
3/31/2025$ 2.18M$ 9.97M$ -7.79M
12/31/2024$ 2.45M$ 9.79M$ -7.34M
9/30/2024$ 3.17M$ 1.14M$ 2.04M
6/30/2024$ 307K$ 14.5M$ -14.19M
3/31/2024$ 335K$ 13.86M$ -13.52M
12/31/2023$ 332K$ 13.14M$ -12.8M
9/30/2023$ 501K$ 12.27M$ -11.77M
6/30/2023$ 348K$ 12.05M$ -11.71M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IMPACT BIOMEDICAL INC's latest trailing twelve months (TTM) Working Capital stands at $ -11.71M.
  • Over the past 5 years, IMPACT BIOMEDICAL INC's average Working Capital has been $ -10.97M.
  • The median Working Capital for IMPACT BIOMEDICAL INC during this period was $ -11.77M
  • IMPACT BIOMEDICAL INC reached its highest Working Capital over the past 5 years at $ 2.04M.
  • The lowest Working Capital recorded by IMPACT BIOMEDICAL INC in the same timeframe $ -21.69M

IMPACT BIOMEDICAL INC's Working Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Working Capital Benchmarks
CompanyWorking Capital
CELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC $ 6.36MTCRT : ALAUNOS THERAPEUTICS INC $ 2.66MADTX : ADITXT INC $ -20.15MHSCS : HEARTSCIENCES INC $ 1.4MPMCB : PHARMACYTE BIOTECH INC $ 18.05MAPVO : APTEVO THERAPEUTICS INC $ 6.19MPALI : PALISADE BIO INC $ 2.48MACXP : ACURX PHARMACEUTICALS INC $ 3.57MGNPX : GENPREX INC $ -380.14KTTNP : TITAN PHARMACEUTICALS INC $ 2.79M

Definition of Working Capital

[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for IMPACT BIOMEDICAL INC is calculated as follows: AssetsC [ $ 348K ] - LiabilitesC [ $ 12.05M ]
(=) Working Capital [ $ -11.71M ]

IBO - Working Capital, Last 5 years

$ -21.69M

Minimum

Jun 30, 2025

$ 2.04M

Maximum

Sep 30, 2024

$ -10.97M

Average

$ -11.77M

Median

Working Capital Benchmark Analysis

The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.44M with a standard deviation of $ 173.86M.
The following table provides additional summary stats:
Working Capital in the Market:
filtered constituents2.78K
min$ -465.2M
max$ 607.04M
average$ 96.44M
median$ 32.21M
std$ 173.86M